Back

Prevalence and characteristics of low-dose acetylsalicylic acid intake in the German population: insights from the German National Cohort (NAKO)

30 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Secondary prevention (2) Secondary Prevention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Johannes Neumann

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

7 More presentations in this session

Presentation thumbnail
The influence of medication costs on secondary cardiovascular prevention decisions: two discrete choice experiments among patients and prescribers
Miss E. Wempe (NL)
Abstract Slides
Presentation thumbnail
Low molecular weight heparin for AMI with frailty: short-Term outcomes after early PCI
Professor K. Chen (Tianjin, CN)
Abstract Slides
Presentation thumbnail
COVID-19 vaccination confers long-term cardioprotection against post-COVID cardiovascular disease: >5-year evidence from causal mediation and target trial emulation
Mr B. Seboka (Melbourne, AU)
Abstract Slides
Presentation thumbnail
The German lipoprotein apheresis registry - summary of the thirteenth annual report
Doctor A. Vogt (Munich, DE)
Abstract Slides
Presentation thumbnail
The newest pillar is the most fragile: SGLT2 inhibitors show the lowest 12-month ongoing use among guideline-directed CAD medications in a 15-country European survey
Mr L. Kieviet (Utrecht, NL)
Abstract Slides

Access the full session

Session thumbnail
Secondary prevention (2)

The Event

Event poster

ESC Congress 2026

30 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Aspirin use for prevention of cardiovascular events in patients with high lipoprotein(a): a population-based study
3 September 2019
thumbnail
Congress Presentation
Describing patient characteristics and the incidence and prevalence of heart failure in Germany: a retrospective database study using AOK Plus - part of the HF-BoI Project
29 June 2021
thumbnail
Congress Presentation
Use of Non-vitamin K antagonist Oral Anticoagulants in a real-world setting: a community pharmacy-based study.
31 August 2019
thumbnail
Congress Presentation
Non-steroidal anti-inflammatory drug use after invasive and non-invasive diagnostic procedures for coronary artery disease by the degree of disease: a Danish drug utilization study (2008-2021)
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources